<--- Back to Details
First PageDocument Content
Biotechnology / EuropaBio / Erik Tambuyzer / European Federation of Pharmaceutical Industries and Associations / Orphan drug / Rare disease / Pharmaceutical industry / European Medicines Agency / Pharmaceutical sciences / Pharmacology / Health
Date: 2011-08-11 10:45:12
Biotechnology
EuropaBio
Erik Tambuyzer
European Federation of Pharmaceutical Industries and Associations
Orphan drug
Rare disease
Pharmaceutical industry
European Medicines Agency
Pharmaceutical sciences
Pharmacology
Health

Add to Reading List

Source URL: www.europabio.org

Download Document from Source Website

File Size: 155,29 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document